Scarica l'app Stockscreener
74.96
0.07%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$74.91
Aprire:
$74.85
Volume 24 ore:
1.33M
Relative Volume:
0.40
Capitalizzazione di mercato:
$16.72B
Reddito:
$4.04B
Utile/perdita netta:
$557.10M
Rapporto P/E:
31.10
EPS:
2.4102
Flusso di cassa netto:
$916.70M
1 W Prestazione:
+0.63%
1M Prestazione:
-0.01%
6M Prestazione:
+16.45%
1 anno Prestazione:
+3.12%
Intervallo 1D:
$74.85
$74.96
Intervallo di 1 settimana:
$74.49
$75.09
Portata 52W:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.96 | 16.71B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
592.27 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.71 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.02 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.21 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.43 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc.HOLX - PR Newswire
Blackstone, TPG Deliver a $7 Billion Test to Risky Loan Market - Bloomberg.com
Assessing Hologic (HOLX) Valuation After Recent Three Month Share Price Momentum - Yahoo Finance
Is Hologic Inc. stock cheap compared to fundamentals2026 world cup usa national team round of 32 defensive leaders build up play tactical prediction statistical analysis - ulpravda.ru
Hologic downgraded to ’B+’ by S&P after take-private deal - Investing.com Australia
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? - The Globe and Mail
How sustainable is Hologic Inc. stock dividend payout2026 world cup usa national team semifinals young talents build up play group prediction expert opinion - ulpravda.ru
Wall Street Banks Kick Off $7 Billion Loan Sale Tied to Hologic Buyout - Bloomberg.com
Hologic Mammography Market Size to Hit USD 8.82 Billion by 2035 - Precedence Research
Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | - openPR.com
Hologic Trading Near 52-Week High: How Should You Play the Stock? - Finviz
Hologic Inc. stock underperforms Thursday when compared to competitors - MSN
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Key facts: Blackstone's stock down 10.2% in 2025; partners with TPG on Hologic - TradingView — Track All Markets
Agree To Buy Hologic At $70, Earn 1.4% Annualized Using Options - Nasdaq
The Future of Bone Sonometer Market 2032 Industry Forecast - openPR.com
Skin Rejuvenation Devices Market Forecast Report: Strategic - openPR.com
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth - Yahoo Finance
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q3 - Yahoo Finance
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open - ts2.tech
Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diamond Hill Investment Group, Inc. (Nasdaq – DHIL), Synchronoss Technologies (Nasdaq – SNCR), Forge Global Holdings, Inc. (NYSE – FRGE), Hologic, Inc. (Nasdaq – HOLX) - GlobeNewswire Inc.
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? - Yahoo Finance
Is Hologic Inc. stock affected by interest rate hikesWeekly Trade Summary & Long-Term Safe Investment Ideas - Улправда
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Why retail investors favor Hologic Inc. stockJuly 2025 Levels & Real-Time Market Sentiment Alerts - Улправда
Will Hologic Inc. (HO1) stock sustain uptrend momentumQuarterly Growth Report & Verified Short-Term Plans - Улправда
Is Hologic Inc. stock positioned for digital transformation2025 Fundamental Recap & Low Drawdown Momentum Ideas - Улправда
Can Hologic Inc. stock maintain operating margins2025 Market WrapUp & AI Optimized Trading Strategy Guides - Улправда
Meeting tomorrow's diagnostic demands in today's lab - SelectScience
Why Hologic Inc. stock is recommended by analystsJuly 2025 Closing Moves & Consistent Return Investment Signals - DonanımHaber
Why Hologic Inc. stock is seen as undervaluedMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Hologic Inc. stock reach Wall Street targetsEarnings Risk Report & Weekly High Conviction Trade Ideas - DonanımHaber
Can Hologic Inc. stock deliver surprise earnings beat2025 Volume Leaders & Real-Time Volume Surge Alerts - Улправда
Digital Breast Tomosynthesis Equipment Market Set to Boom | - openPR.com
Is Hologic Inc. stock gaining market shareJuly 2025 Big Picture & AI Powered Market Trend Analysis - ulpravda.ru
Market Outlook: Will Hologic Inc. (HO1) stock sustain uptrend momentumMarket Growth Summary & Free Accurate Trade Setup Notifications - moha.gov.vn
Hologic data highlights AI’s role in improving mammography accuracy - DOTmed
Portfolio Shifts: Can Hologic Inc. stock maintain operating marginsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Hologic (HOLX) shareholders have earned a 4.8% return over the last year - Yahoo Finance
Responsive Playbooks and the HOLX Inflection - news.stocktradersdaily.com
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers - sharewise.com
Hologic (HOLX) insider reports 90 shares withheld for tax obligations - Stock Titan
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases - Yahoo Finance
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bacterial Drug Sensitivity Testing Market Future Outlook - openPR.com
Uterine Fibroid Treatment Market Forecast to 2032 Reveals Key - openPR.com
Virtual Biopsy Market Emerging Player Outperforming | GE Healthcare, Hologic, Hitachi - openPR.com
Hologic’s AI mammography tech flags previously missed breast cancers - Investing.com India
Study: AI-Powered Mammography Technology Helps Flag Breast Cancer Cases Initially Interpreted as Negative - Imaging Technology News
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
1.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):